Fabrikant-profiel
American Regent, Inc.
Farmaceutisch bedrijf4 producten gevolgd
4
producten gevolgd
19.384
totaal meldingen
4
recalls geregistreerd
63,4%
ernstig algeheel
Producten
4 van 4 getoond
| Product | Goedgekeurd | Meldingen ↓ | Top signaal | Recalls |
|---|---|---|---|---|
| 1978 | 8.660 | productafzetting | 0 | |
| 2013 | 4.574 | Hypofosfatemie | 1 | |
| — | 4.574 | Hypofosfatemie | 0 | |
| 1986 | 1.576 | ontsteking nagelbed | 3 |
Recall-geschiedenis · 11 geregistreerd
| Datum | Klasse | Reden | Bedrijf |
|---|---|---|---|
| 16 apr 2026 | III | Labeling: Missing Label | American Regent, Inc. |
| 18 apr 2025 | II | Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. | American Regent, Inc. |
| 18 apr 2025 | II | Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. | American Regent, Inc. |
| 11 nov 2024 | II | Presence of Particulate Matter: Potential for glass delamination from the vials. | American Regent, Inc. |
| 11 nov 2024 | II | Presence of Particulate Matter: Potential for glass delamination from the vials. | American Regent, Inc. |
| 11 nov 2024 | II | Presence of Particulate Matter: Potential for glass delamination from the vials. | American Regent, Inc. |
| 14 mei 2024 | II | Lack of Assurance of Sterility. | American Regent, Inc. |
| 18 jun 2019 | II | Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance. | Premier Pharmacy Labs Inc |
| 12 jun 2019 | II | Lack of Assurance of Sterility | Infusion Options, Inc. |
| 24 feb 2015 | II | Presence of particulate. | SCA Pharmaceuticals |
| 14 nov 2014 | II | Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin. | Attix Pharmaceuticals |
Class I = redelijke kans op ernstige schade · Class II = tijdelijk of omkeerbaar · Class III = onwaarschijnlijk schadelijk.
Registratiestatus
Sommige producten van American Regent, Inc. zijn niet FDA-geregistreerd voor humaan gebruik. Voor ongeregistreerde stoffen (peptiden, SARMs zonder humane registratie) bestaat geen legitieme leverancier voor humaan gebruik. Het ontbreken van een inkooproute is de veiligheidsinformatie.